health
India’s first dengue vaccine arrives with a crucial safety caveat
Archived — last updated
India’s first dengue vaccine arrives with a crucial safety caveat Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Latest updates
India’s first dengue vaccine arrives with a crucial safety caveat
India’s first dengue vaccine arrives with a crucial safety caveat Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News. Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
India's First Dengue Vaccine Arrives with Crucial Safety Caveat
India's drug regulator has approved the country's first dengue vaccine, Qdenga. The vaccine is designed to protect against the four serotypes of the dengue-causing virus, called DENV-1 to DENV-4. Young children as well as adults (aged 4-60 years), irrespective of whether they have had dengue before, may be vaccinated with Qdenga. The vaccine has been approved for use in over 40 countries, including Japan, where it is manufactured by the Japanese pharma company, Takeda.
India Launches First Dengue Vaccine, Eligibility Criteria Revealed
The Indian government has launched its first dengue vaccine, with the eligibility criteria for the vaccine being announced. The vaccine is recommended for individuals aged 9-45 years who have a history of dengue fever or are at high risk of contracting the disease. The vaccine has been developed by a private company in collaboration with the Indian government. The government has stated that the vaccine will be available at all government hospitals and private hospitals across the country. The vaccine will be administered in two doses, with the second dose to be given after 28 days of the first dose. The government has also announced that the vaccine will be available at a subsidized rate for low-income individuals.
On guard: on India and the Qdenga dengue vaccine
On guard: on India and the Qdenga dengue vaccine India Approves First Dengue Vaccine for People Aged 4 to 60.
On guard: on India and the Qdenga dengue vaccine
On guard: on India and the Qdenga dengue vaccine Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News. Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
India Approves First Dengue Vaccine
India has approved its first dengue vaccine, Qdenga, which has been licensed in over 40 countries and prequalified by the WHO. The vaccine is expected to help combat the spread of dengue fever in the country, where the disease has been a major public health concern. The Aedes mosquitoes that spread the disease are expanding into semi-urban and rural districts, where conventional vector control is harder to sustain. The Indian government has been working to improve surveillance and control measures to combat the spread of dengue fever.
Who should get India's first dengue vaccine? Kolkata doctors explain
Who should get India's first dengue vaccine? Kolkata doctors explain Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News. Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Who should get India's first dengue vaccine? Kolkata doctors explain
Who should get India's first dengue vaccine? Kolkata doctors explain Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News. Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Who should get India's first dengue vaccine? Kolkata doctors explain
Kolkata doctors are discussing who should receive India's first dengue vaccine, which is expected to be launched soon. The vaccine is expected to provide protection against dengue fever, a mosquito-borne disease. The doctors are considering various factors, including age and health status, to determine who should receive the vaccine. The vaccine is expected to be launched in the near future, and the doctors are preparing for its introduction. The launch of the vaccine is expected to provide relief to people who are at risk of contracting dengue fever.
Takeda’s QDENGA Becomes India’s First Approved Dengue Vaccine
Takeda’s QDENGA Becomes India’s First Approved Dengue Vaccine Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News. Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Takeda's QDENGA Becomes India's First Approved Dengue Vaccine
Takeda's QDENGA has become India's first approved dengue vaccine. The vaccine has been approved by the Indian government for use in the country. The approval of QDENGA is a significant development in the fight against dengue fever in India. The vaccine has been shown to be effective in preventing dengue fever in clinical trials. The Indian government has approved the use of QDENGA in the country, making it the first dengue vaccine to be approved in India. The approval of QDENGA is a major milestone in the fight against dengue fever in India.
India approves first dengue vaccine QDENGA for ages 4–60
The Drug Controller General of India (DCGI) approved Takeda Biopharmaceuticals India’s dengue vaccine QDENGA on July 22, 2026, making it the first such vaccine authorized in India. The vaccine is approved for use in individuals aged 4 to 60 years. Takeda stated the approval is a significant step in combating dengue, a mosquito-borne disease that impacts millions in India each year. The company did not specify the vaccine’s pricing or availability timeline in its announcement.
India Has a Dengue Vaccine, Now It Needs a Strategy
India has developed a dengue vaccine, but the country still lacks a comprehensive strategy to tackle the disease. The vaccine is expected to be rolled out in the coming months, but experts are warning that a strategy is needed to ensure its effectiveness. The vaccine has been developed by a team of scientists at the Indian Council of Medical Research, and is expected to provide immunity against dengue fever. However, experts are warning that a strategy is needed to ensure that the vaccine is used effectively and that the disease is tackled at its root cause. The government has announced plans to launch a nationwide campaign to promote the use of the vaccine, but experts are warning that more needs to be done.
India Has A Dengue Vaccine. Now It Needs A Strategy
India has developed a dengue vaccine, but the government needs to formulate a strategy for its distribution and implementation to combat the disease effectively. The vaccine has been developed by a private company, and the government is yet to decide on its pricing and availability. According to the World Health Organization, dengue fever affects over 390 million people worldwide each year, and India is one of the countries most affected by the disease. The government needs to ensure that the vaccine is available to those who need it most, particularly in rural areas where access to healthcare is limited. The government also needs to educate the public about the vaccine and its benefits to increase its adoption.
India Has a Dengue Vaccine, But Needs a Strategy to Use It
India has developed a dengue vaccine, but the country lacks a comprehensive strategy to implement its use, leaving millions of people vulnerable to the disease. Experts say a well-planned approach is needed to make the vaccine accessible and effective. The vaccine has shown promising results in clinical trials, but its widespread adoption is hindered by lack of infrastructure and resources. A coordinated effort is required to ensure the vaccine reaches those who need it most.
Sources
- Via The Hindunews.google.com
- Via The Hinduthehindu.com
- Via BW Healthcare Worldnews.google.com
- Via The Hindunews.google.com
- Via Devdiscoursenews.google.com
- Via The Hinduthehindu.com
- Via News On AIRnewsonair.gov.in
- Via Telegraph Indianews.google.com
- Via Telegraph Indianews.google.com
- Via eHealth Magazinenews.google.com
- Via The Indian Practitionernews.google.com
- Via Drishti IASnews.google.com
- Via NDTVndtv.com
AI-assisted summary of the reporting above. Quotes are kept to one sentence. Copyright concern? See our DMCA takedown page.